Evidence map›Paper›PMID 26293980›Full record

ReviewPediatric nephrology (Berlin, Germany)2016

Fibroblast growth factor receptor signaling in kidney and lower urinary tract development.

Kenneth A Walker, Sunder Sims-Lucas, Carlton M Bates

Abstract readReview
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. The kidney stroma in development and disease.Nature reviews. Nephrology · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. The dynamics of tubulogenesis in development and disease.Development (Cambridge, England) · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Aberrations inInternational journal of molecular sciences · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Evaluation of PGP 9.5, NGFR, TGFβ1, FGFR1, MMP-2, AT2R2, SHH, and TUNEL in Primary Obstructive Megaureter Tissue.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Article
  19. Frontiers in medicine · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kenneth A WalkerDivision of Nephrology, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Sunder Sims-LucasDivision of Nephrology, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Carlton M BatesDivision of Nephrology, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. batescm@upmc.edu.
University of Pittsburgh · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Single Nephron and MetabolomicsP30DK079307 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLEYMAN, THOMAS R · 2008 to 2022
$13.4M
Role of FGF Receptors in the Developing KidneyR01DK070030 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BATES, CARLTON MATTHEW · 2005 to 2009
$1.5M
A genetic model of vesicoureteral reflux and reflux nephropathyR01DK081128 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BATES, CARLTON MATTHEW · 2009 to 2012
$1.4M
Critical Roles for Fibroblast Growth Factor Receptors in Bladder DevelopmentR01DK104374 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BATES, CARLTON MATTHEW · 2015 to 2018
$1.4M
Role of Receptors in the Metanephric MesenchymeR01DK095748 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BATES, CARLTON MATTHEW · 2013 to 2016
$1.4M
NCATS NIH HHS UL1 TR000005NIDDK NIH HHS P30 DK079307NIDDK NIH HHS R01 DK 070030NIDDK NIH HHS R01 DK070030NIDDK NIH HHS R01 DK 081128NIDDK NIH HHS R01 DK081128NIDDK NIH HHS R01 DK095748NIDDK NIH HHS R01 DK104374
6 · The paper itself

Abstract

Fibroblast growth factor receptors (FGFRs) and FGF ligands are highly expressed in the developing kidney and lower urinary tract. Several classic studies showed many effects of exogenous FGF ligands on embryonic renal tissues in vitro and in vivo. Another older landmark publication showed that mice with a dominant negative Fgfr fragment had severe renal dysplasia. Together, these studies revealed the importance of FGFR signaling in kidney and lower urinary tract development. With the advent of modern gene targeting techniques, including conditional knockout approaches, several publications have revealed critical roles for FGFR signaling in many lineages of the kidney and lower urinary tract at different stages of development. FGFR signaling has been shown to be critical for early metanephric mesenchymal patterning, Wolffian duct patterning including induction of the ureteric bud, ureteric bud branching morphogenesis, nephron progenitor survival and nephrogenesis, and bladder mesenchyme patterning. FGFRs pattern these tissues by interacting with many other growth factor signaling pathways. Moreover, the many genetic Fgfr and Fgf animal models have structural defects mimicking numerous congenital anomalies of the kidney and urinary tract seen in humans. Finally, many studies have shown how FGFR signaling is critical for kidney and lower urinary tract patterning in humans.

Indexed as

OrganogenesisAcanthosis NigricansAcrocephalosyndactyliaAnimalsAntley-Bixler Syndrome PhenotypeApoptosisCraniosynostosesEarFibroblast Growth FactorsGene Knockout TechniquesHumansKidneyMiceModels, AnimalMutationReceptors, Fibroblast Growth FactorFibroblast Growth FactorsReceptors, Fibroblast Growth FactorT-Box Domain ProteinsTbx18 protein, mouseBladder organogenesisConditional knockoutFibroblast growth factorsMetanephric mesenchymeRenal organogenesisUreteric bud

Identifiers

PMID26293980
PMCPMC4761523
OpenAlexW1159598077

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.